 1. Exposure models used in calculating regulatory CVA must be part of a CVA risk management framework subject to senior management oversight.


2. An independent risk control unit must validate exposure models annually and report directly to senior management.


3. The validation process must be documented in detail, including the frequency of validation and circumstances requiring more frequent validation.


4. Pricing models must be tested against independent benchmarks, and an independent review of the CVA risk management process must be conducted regularly.


5. A [BANKING ORGANIZATION] must define criteria to assess exposure models, verify transactions are assigned to the appropriate netting set, and ensure transaction terms and specifications are accurately reflected in the model.